CI
MRNA icon

CX Institutional’s Moderna MRNA Stock Holding History

CX Institutional’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$611K Buy
8,720
+817
+10% +$42.3K 0.02% 417
2026
Q1 		$401K Sell
7,903
-218
-3% -$10.2K 0.01% 516
2025
Q4 		$239K Buy
8,121
+1,000
+14% +$27.2K 0.01% 648
2025
Q3 		$184K Buy
7,121
+6,088
+589% +$170K 0.01% 715
2025
Q2 		$29K Buy
1,033
+949
+1,130% +$25K ﹤0.01% 924
2025
Q1 		$2K Buy
+84
New +$2.98K ﹤0.01% 1144
2024
Q3 		– Sell
-4,437
Closed -$527K – 587
2024
Q2 		$527K Buy
4,437
+1,471
+50% +$186K 0.02% 364
2024
Q1 		$316K Buy
2,966
+591
+25% +$59.6K 0.02% 442
2023
Q4 		$236K Buy
+2,375
New +$200K 0.01% 458
2023
Q2 		– Sell
-2,234
Closed -$352K – 526
2023
Q1 		$352K Buy
2,234
+997
+81% +$164K 0.02% 392
2022
Q4 		$222K Buy
+1,237
New +$202K 0.01% 481
2022
Q3 		– Sell
-61
Closed -$9K – 889
2022
Q2 		$9K Buy
+61
New +$8.72K ﹤0.01% 965
2021
Q4 		– Sell
-13
Closed -$5K – 711
2021
Q3 		$5K Buy
+13
New +$4.79K ﹤0.01% 866

Other funds holding MRNA

DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
LAI
Legal Advantage Investments Los Altos Hills, California $285M AUM 18.63% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
1WA
180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

CX Institutional's MRNA Position: Q2 2026 in Review

CX Institutional increased its Moderna (MRNA) stake by 10% in Q2 2026, buying an estimated $42.3K and bringing the position to 8,720 shares worth $611K. The position accounts for 0.02% of the portfolio, ranked #417.

CX Institutional first reported a position in MRNA in Q3 2021 and has held it in 13 quarters since. 112 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • CX Institutional held 8,720 shares of Moderna worth $611K as of Q2 2026.
  • CX Institutional bought 817 Moderna shares in Q2 2026, an estimated $42.3K.
  • Moderna made up 0.02% of CX Institutional's portfolio in Q2 2026, its #417 holding.
  • CX Institutional first reported a position in Moderna in Q3 2021 and has held it in 13 quarters since.
  • 112 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on CX Institutional's 13F filing for Q2 2026, filed 2 Jul 2026.